Blog

Beyond Compliance: What ICH M15 Means for the Future of Drug Development

Explore how ICH M15 is shaping regulatory expectations for Model-Informed Drug Development (MIDD), including model…

CertaraJune 9, 2026

Blog

How interactive value communication tools strengthen the value proposition in healthcare

Learn how interactive value communication tools help demonstrate healthcare value, support payer discussions, and strengthen…

CertaraJune 9, 2026

Press Coverage

The Case for Simulating Pregnancy

Pregnant women are routinely excluded from drug trials, leaving clinicians without dosing guidance. Discover how…

CertaraJune 9, 2026

Blog

The end of the national launch: why regional pharma market access now determines commercial success

Regional pharma market access is reshaping uptake. Build a regional market access strategy to navigate…

CertaraJune 5, 2026

Publication

Clinical Validation of a QSP Model for ISB 2001, a Trispecific T Cell Engager to Support Optimal FIH Study Design in RRMM Patients

See how a QSP model guided efficacy-proximal FIH dosing for ISB 2001 in the TRIgnite-1…

CertaraJune 4, 2026

Video

Applying AI-Driven Biosimulation to Drug Discovery

Certara President Leif Pedersen explains how PBPK and QSP modeling, proven across 125+ FDA-approved drugs,…

CertaraJune 2, 2026

Case Study

Model-Informed Development Accelerates Transformative Treatment for Sleeping Sickness

Certara’s drug development support enabled a positive scientific opinion from the EMA for acoziborole, a…

CertaraJune 2, 2026

Blog

Strategies for navigating loss of exclusivity (LOE) in pharma

Learn key strategies to navigate loss of exclusivity with confidence & defend market share throughout…

CertaraJune 2, 2026

Publication

Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment

This review explores how artificial intelligence (AI), machine learning (ML), and quantitative systems pharmacology (QSP)…

CertaraJune 2, 2026

Webinar

Model Acceptance in Regulatory Submissions: Practical Strategies for Regulatory Success

CertaraJune 1, 2026

Beyond Compliance: What ICH M15 Means for the Future of Drug Development

How interactive value communication tools strengthen the value proposition in healthcare

The Case for Simulating Pregnancy

The end of the national launch: why regional pharma market access now determines commercial success

Clinical Validation of a QSP Model for ISB 2001, a Trispecific T Cell Engager to Support Optimal FIH Study Design in RRMM Patients

Applying AI-Driven Biosimulation to Drug Discovery

Model-Informed Development Accelerates Transformative Treatment for Sleeping Sickness

Strategies for navigating loss of exclusivity (LOE) in pharma

Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment

Model Acceptance in Regulatory Submissions: Practical Strategies for Regulatory Success

Newsletter sign up

Quick links

Solutions

Contact